Concentration, delivery method, duration, and the specific outcome being measured all shift the GHK-Cu timeline
PMID: 38611056
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
Accelerated aging, damaged or mutated cells, broken-down tissue, the activation of harmful genes within DNA, and an overloaded immune system
Possible Complications Possible complications of EDS include: Chronic joint pain Early-onset arthritis Failure of surgical wounds to close (or stitches tear out) Premature rupture of membranes during pregnancy Rupture of major vessels, including a ruptured aortic aneurysm (only in vascular EDS) Rupture of a hollow organ such as the uterus or bowel (only in vascular EDS) Rupture of the eyeball (only in vascular EDS) When to Contact a Medical Professional Contact your provider for an appointment if you have a family history of EDS and you are concerned about your risk or are planning to start a family
This treatment is not appropriate for individuals with active infections, immunocompromised states, or contraindications determined by clinical evaluation